This study shows that UB can regulate the tumor microenvironment of colon cancer, upregulate NK cells and γδ T cells, inhibit Treg cells, improve immune response, PD-L1, and upregulate the response of immune regulatory flora after combination with capecitabine. Here, CD274 is linked to colonic neoplasm.